What is LOPJLB’s current signal on ORGO?

LOPJLB’s latest quantitative signal on Organogenesis Holdings Inc. (ORGO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ORGO in?

Organogenesis Holdings Inc. (ORGO) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Organogenesis Holdings Inc. based / listed?

Organogenesis Holdings Inc. is based in US, listed on NASDAQ.

Organogenesis Holdings Inc. (ORGO)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

$1.28-3.03%Close

SELLCRISIS · day 44

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $165M
Beta: 1.29
P/E (TTM): -1.63

Short % float: 24.61%
Days to cover: 18.8
SI change: -0.9%

1W: -8.57%
1M: -18.47%

vs SPY 1W: -10.13%
vs SPY 1M: -20.24%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio,…

Employees: 854
Headquarters: US
Founded: 2017
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 128.7M
Float: 44.6%

organogenesis.com ↗

Key executives

Gary S. Gillheeney — President, Chief Executive Officer, Chair of the Board

Lori H. Freedman — Chief Administrative & Legal Officer

Brian Grow — Chief Commercial Officer

SEC filings

EDGAR · CIK 16611810 · ORGO

Analyst consensus

Buy

Bullish466.7%

Neutral233.3%

Bearish00.0%

L $2.00Avg $2.50H $3.00

Target$2.50+95.31%

Last$1.28

Key stats

Industry peers

Prediction markets

Company news